Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial

Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial

Introduction Treatment of latent tuberculosis infection (LTBI) plays a substantial role in the prevention of drug-susceptible tuberculosis (TB). However, clinical trials to evaluate the efficacy of preventive therapy for presumed multidrug-resistant (MDR) LTBI are lacking. This trial aims to evaluat...

Full description

Saved in:
Bibliographic Details
Main Authors: Ben J Marais, Andrea Benedetti, David W Dowdy, Dick Menzies, Marcel A Behr, Greg J Fox, Cam Binh Nguyen, Thu Anh Nguyen, Phuong Thuy Tran, Steve M Graham, Binh Hoa Nguyen, Kavi Velen, Paul Mason, Warwick J Britton, Viet Nhung Nguyen, Guy B Marks
Format: Article
Language:English
Published: BMJ Publishing Group 2020-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/1/e033945.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/10/1/e033945.full

Similar Items